Minimal Residual Disease and Survival Outcomes in Patients With Multiple Myeloma After ASCT and Maintenance With Lenalidomide
Written by Rafael Fonseca MD
Written by Rafael Fonseca MD
MISSOURI (KSNF) — One university in the Show-Me State receives high marks on a global scale. Washington University in St. Louis (WUSTL) is ranked 8th…
Study in Blood dissecting the role of NFκB signaling effectors in MPN disease biology Stephen T. Oh, MD, PhD, Co-Chief and Associate Professor of Medicine,…
Herbicide and pesticide exposure [e.g., agent orange (AO)] is associated with an increased risk of multiple myeloma (MM) due to the contaminant, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). However,…
ST. LOUIS – The St. Louis Blues are preparing to recognize the 25th Anniversary of the National Hockey League’s fight against cancer when they host…
While the flesh-eating undead portrayed on television are just fiction, there are clear examples of parasites that have evolved to manipulate their hosts, according to…
The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing…
This Viewpoint discusses the unfairness of current CAR T-cell therapy allocation practices and offers alternative methods to more fairly allocate therapy.
Read it now on PracticeUpdate.com
Read it now on PracticeUpdate.com